A Study Of Cisplatin (Or Carboplatin) And Etoposide With Or Without Figitumumab (CP-751,871) In Patients With Extensive-Stage Small Cell Lung Cancer

PHASE2TerminatedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

April 30, 2010

Primary Completion Date

October 31, 2011

Study Completion Date

October 31, 2011

Conditions
Small Cell Lung Carcinoma
Interventions
DRUG

figitumumab

Figitumumab (20 mg/kg)

DRUG

Cisplatin (Or Carboplatin)

Cisplatin (75 mg/m2 IV on Day 1) or Carboplatin AUC 5

DRUG

Etoposide

Etoposide (100 mg/m2 IV on Days 1, 2 and 3)

DRUG

Cisplatin (Or Carboplatin)

Cisplatin (75 mg/m2 IV on Day 1) or Carboplatin AUC 5

DRUG

Etoposide

Etoposide (100 mg/m2 IV on Days 1, 2 and 3)

Trial Locations (51)

1125

Pfizer Investigational Site, Budapest

2045

Pfizer Investigational Site, Törökbálint

4032

Pfizer Investigational Site, Debrecen

6772

Pfizer Investigational Site, Deszk

8582

Pfizer Investigational Site, Farkasgyepű

19611

Pfizer Investigational Site, West Reading

20007

Pfizer Investigational Site, Washington D.C.

24014

Pfizer Investigational Site, Roanoke

24074

Pfizer Investigational Site, Christiansburg

24153

Pfizer Investigational Site, Salem

24382

Pfizer Investigational Site, Wytheville

24457

Pfizer Investigational Site, Low Moor

27030

Pfizer Investigational Site, Mount Airy

27103

Pfizer Investigational Site, Winston-Salem

27284

Pfizer Investigational Site, Kernersville

27295

Pfizer Investigational Site, Lexington

28041

Pfizer Investigational Site, Madrid

28602

Pfizer Investigational Site, Hickory

28645

Pfizer Investigational Site, Lenoir

28659

Pfizer Investigational Site, North Wilkesboro

29010

Pfizer Investigational Site, Málaga

35016

Pfizer Investigational Site, Las Palmas de Gran Canaria

41009

Pfizer Investigational Site, Seville

41013

Pfizer Investigational Site, Seville

46026

Pfizer Investigational Site, Valencia

63110

Pfizer Investigational Site, St Louis

63141

Pfizer Investigational Site, Creve Coeur

63376

Pfizer Investigational Site, City of Saint Peters

70006

Pfizer Investigational Site, Metairie

70072

Pfizer Investigational Site, Marrero

97006

Pfizer Investigational Site, Beaverton

97030

Pfizer Investigational Site, Gresham

97062

Pfizer Investigational Site, Tualatin

97210

Pfizer Investigational Site, Portland

97239

Pfizer Investigational Site, Portland

98003

Pfizer Investigational Site, Federal Way

98201

Pfizer Investigational Site, Everett

98332

Pfizer Investigational Site, Gig Harbor

98372

Pfizer Investigational Site, Puyallup

98405

Pfizer Investigational Site, Tacoma

98499

Pfizer Investigational Site, Lakewood

99336

Pfizer Investigational Site, Kennewick

20007-2197

Pfizer Investigational Site, Washington D.C.

63110-1094

Pfizer Investigational Site, St Louis

07962

Pfizer Investigational Site, Morristown

P3E 5J1

Pfizer Investigational Site, Greater Sudbury

L1G 2B9

Pfizer Investigational Site, Oshawa

G6V 3Z1

Pfizer Investigational Site, Lévis

H4J 1C5

Pfizer Investigational Site, Montreal

08025

Pfizer Investigational Site, Barcelona

08036

Pfizer Investigational Site, Barcelona

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT00977561 - A Study Of Cisplatin (Or Carboplatin) And Etoposide With Or Without Figitumumab (CP-751,871) In Patients With Extensive-Stage Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter